1. Introduction {#sec1-ijerph-16-04529}
===============

Obesity is defined as being an excess of adipose tissue that may cause health problems \[[@B1-ijerph-16-04529]\] and is considered a key risk factor in the development of several chronic diseases such as ischemic heart disease, arterial hypertension, the onset and recovery difficulties of osteo-articular problems, some types of cancer, alterations in the fecundity capacity of men and women, and all-cause mortality \[[@B2-ijerph-16-04529],[@B3-ijerph-16-04529],[@B4-ijerph-16-04529],[@B5-ijerph-16-04529],[@B6-ijerph-16-04529]\]. The prevalence of being overweight and obesity is continuously increasing, having increased up to 39% and 13%, respectively in 2016 worldwide \[[@B7-ijerph-16-04529]\].

Scientific evidence has demonstrated how the amount of body fat and its distribution are influenced by diverse factors, like sex, age, and suffering from certain pathologies or under particular circumstances \[[@B8-ijerph-16-04529],[@B9-ijerph-16-04529],[@B10-ijerph-16-04529]\]. Body fat, both visceral and subcutaneous, is closely related to increased insulin resistance and the subsequent development of metabolic syndrome and type 2 diabetes mellitus \[[@B11-ijerph-16-04529]\], which makes it a useful clinical parameter for the prediction and prevention of these diseases.

Several methods are available for measuring body fat, including computerized axial tomography (CT), magnetic resonance imaging (MRI), dual-energy X-ray absorptiometry (DXA), air displacement plethysmography (ADP), and the evaluation of body composition with a four-component model. The latter is based on several techniques (ADP or hydrostatic weighing (UWW), deuterium dilution, and DXA), and is considered to be the gold standard \[[@B12-ijerph-16-04529],[@B13-ijerph-16-04529]\]. However, given the issues with using these techniques (large-size devices, high costs, use of radiation, etc.), using them for a body composition study in clinical practice, despite their accuracy, is challenging \[[@B14-ijerph-16-04529],[@B15-ijerph-16-04529]\].

For that reason, researchers have formulated diverse equations for the estimation of different parameters. With regard to body fat percentage (BF%), simple access indexes are available, such as the body mass index (BMI) \[[@B16-ijerph-16-04529]\] or the body adiposity index (BAI) \[[@B14-ijerph-16-04529]\], among others \[[@B17-ijerph-16-04529]\]. Other formulas frequently employed, as they are non-invasive and easy to apply \[[@B18-ijerph-16-04529]\], are based on the measurement of body folds. However, deciding which formula to use for its precision and efficiency continues to be a controversial subject both in clinical and research contexts. BMI and BAI are still under debate due to their low correlation with body fat percentage for two reasons: Both do not consider important variables such as age, sex, and because they do not indicate body composition \[[@B14-ijerph-16-04529],[@B16-ijerph-16-04529]\]. Similarly, due to the large variability in the population to which they are applied, and depending on the professional obtaining the measurements, estimations based on the study of skin folds are also disputed \[[@B18-ijerph-16-04529],[@B19-ijerph-16-04529],[@B20-ijerph-16-04529]\].

Gómez-Ambrosi et al. developed a body fat estimator, the Clínica Universidad de Navarra-Body Adiposity Estimator (CUN-BAE), using ADP, and obtained a correlation of 0.89 with only three variables (age, sex, and BMI) \[[@B21-ijerph-16-04529]\]. This formula also achieved good results for the detection of cardiometabolic risk factors when compared with other indexes used for this purpose. CUN-BAE has shown a strong association with metabolic syndrome risk in women (odds ratio (OR) = 6.12) and men (OR = 5.83) \[[@B22-ijerph-16-04529]\], arterial hypertension, and type 2 diabetes mellitus \[[@B23-ijerph-16-04529]\], which pathologies with a high prevalence \[[@B24-ijerph-16-04529],[@B25-ijerph-16-04529]\]. As has been demonstrated in other works \[[@B26-ijerph-16-04529]\], this estimator is complex due to requiring a calculation with nine components ($(CUN - BAE~\left( {BF\%} \right)~ = ~ - 44.988~ + ~\left( {0.503 \times Age} \right)~ + ~\left( {10.689 \times Sex} \right)~ + ~\left( {3.172 \times BMI} \right)~ - ~\left( {0.026 \times BMI^{2}} \right)~ + ~\left( {0.181 \times BMI \times Sex} \right)~ - ~\left( {0.02 \times BMI \times Age} \right)~ - ~\left( {0.005 \times BMI^{2} \times Sex} \right)~ + ~\left( {0.00021 \times BMI^{2} \times Age} \right)$, in which a man = 0 and a woman = 1 for the sex variable). However, despite the relevance of CUN-BAE, it could be improved for two reasons. Firstly, as highlighted in other research, it is difficult to calculate because it requires nine components. The principle of parsimony, or Ockham's razor principle, recommends using the simplest model that best fits the measurements. Thus, over-fitting, which means adding more variables to the model, to explain more variability, is considered a methodological limitation \[[@B27-ijerph-16-04529],[@B28-ijerph-16-04529]\]. However, its complexity means that in clinical real settings, in which software for calculation may not be available, CUN-BAE cannot be used. Since the CUN-BAE is associated with the risk of suffering from the most frequent chronic diseases, its access must be guaranteed in all circumstances, demonstrating the need for the simplest modeling possible, as has been conducted in other populations \[[@B29-ijerph-16-04529]\].

For these reasons, the objective of this study was to develop and validate a new body fat estimation equation, reducing the factors required, simplifying the final formula, respecting the principle of parsimony for multivariate modeling, and using the estimations of the CUN-BAE as a reference.

2. Materials and Methods {#sec2-ijerph-16-04529}
========================

2.1. Study Design, Population, and Sample {#sec2dot1-ijerph-16-04529}
-----------------------------------------

This research was conducted in two phases. All data were collected from the staff at the City Council of Córdoba (Spain).

### 2.1.1. Phase I {#sec2dot1dot1-ijerph-16-04529}

Phase I was a cross-sectional study with the aim of creating a tool for the estimation of BF% with respect to the reference method (CUN-BAE). The sample (n~1~) was composed of 906 workers selected randomly among those who had underwent an occupational health examination at the City Council Occupational Health Uni, during the period between 2017 and 2019.

### 2.1.2. Phase II {#sec2dot1dot2-ijerph-16-04529}

The purpose of the second phase was to verify the precision of the proposed estimation method. It was performed with a sample (n~2~) of 2000 workers, randomly selected among those employed during the period between 2018 and 2019. The workers included in the one sample did not participate in the other (the n~1~ and n~2~ samples were mutually exclusive).

2.2. Study Variables and Measurement {#sec2dot2-ijerph-16-04529}
------------------------------------

The BF% (result variable) was calculated using the formula proposed by the Clínica Universidad de Navarra, the CUN-BAE \[[@B21-ijerph-16-04529]\], and used as the reference method (gold standard):$$\begin{array}{l}
{CUN - BAE~\left( {BF\%} \right) =} \\
{\quad\quad\quad\quad\quad\quad\quad\quad - 44.988~ + ~\left( {0.503~ \times ~Age} \right)~ + ~\left( {10.689~ \times ~Sex} \right)~} \\
{\quad\quad\quad\quad\quad\quad\quad\quad + ~\left( {3.172 \times ~BMI} \right)~ - ~\left( {0.026~ \times ~BMI^{2}} \right)~ + ~\left( {0.181~ \times ~BMI~ \times ~Sex} \right)~} \\
{\quad\quad\quad\quad\quad\quad\quad\quad - ~\left( {0.02~ \times ~BMI~ \times ~Age} \right)~ - ~\left( {0.005~ \times ~BMI^{2} \times Sex} \right)~} \\
{\quad\quad\quad\quad\quad\quad\quad\quad + ~\left( {0.00021~ \times ~BMI^{2} \times ~Age} \right)} \\
\end{array}$$

The independent variables collected were: Sex (men and women), age (in years), weight (kg), height (cm), and BMI (kg/m^2^).

The anthropometric measurements were recorded following the recommendations in the standardized anthropometry reference manual \[[@B30-ijerph-16-04529]\] by experienced staff to decrease the variation coefficient. Each measurement was recorded three times and the mean value was calculated. The height and weight were measured with a precision of 0.1 cm and 0.1 kg, respectively, using a stadiometer and Atlántida S11 balance (Básculas y Balanzas Añó-Sayol, Barcelona, Spain)

To classify the nutritional state of the study population according to their BMI, the recommendation established by the World Health Organization (WHO) \[[@B31-ijerph-16-04529]\] was followed. The sample was categorized in terms of the body fat estimated by the CUN-BAE formula, in accordance with the cut-off points for a Caucasian population \[[@B32-ijerph-16-04529]\]: For women: Normal weight, ≤30%; overweight, 30.1%--35%; obese, \>35.1%; and Men: normal weight, ≤20%; overweight, 20.1%--25%; obese, \>25.1%.

2.3. Ethical and Legal Aspects {#sec2dot3-ijerph-16-04529}
------------------------------

All the workers were informed, verbally and in writing, of the objectives of the health study to which they were being submitted, and an informed consent was obtained from each in compliance with the current regulations. The study's protocol complied with the Declaration of Helsinki for conducting medical research involving human subjects and was approved by Bioethics Committee of Córdoba (Spain) (4427/Acta number 295).

2.4. Statistical Analysis {#sec2dot4-ijerph-16-04529}
-------------------------

The quantitative variables are presented as the mean and standard deviation, the qualitative values presented as frequencies and percentages.

To contrast the goodness-of-fit to a normal distribution of the data from the quantitative variables, the Kolmogorov--Smirnov test with the Lilliefors correction was employed. The Student's *t*-test for two means was performed for the bivariate hypothesis contrast, whereas for the qualitative variables, the Chi-square and Fisher exact test were used when necessary. In addition, for the correlation between the quantitative variables, the Pearson's correlation coefficient (*r*) was used.

We used raw linear regressions with each predictive variable and adjusted linear models to obtain new body fat estimation formulas. To determine the goodness-of-fit of the models, we analyzed the standard error, the adjusted coefficient of determination, the F statistic, the linearity analysis, and the residues.

We quantitatively analyzed the degree of concordance with the reference method with the intraclass correlation coefficient (ICC) and, graphically, with the Bland--Altman Method, used the sample n~2~ for this purpose.

For all the statistical analyses, the probability of an α error of below 5% (*p* \< 0.05) was considered statistically significant and the confidence interval was calculated at 95%. For the statistical analysis, IBM SPSS Statistics 22.0 software (IBM, Chicago, IL, USA) and Epidat 4.2. (Department of Sanidade, Xunta de Galicia, Galicia, Spain) were used.

3. Results {#sec3-ijerph-16-04529}
==========

3.1. Prevalence of Overweight and Obesity (n~1~) {#sec3dot1-ijerph-16-04529}
------------------------------------------------

Out of a total of 906 workers, 63.1% were men. The mean age was of 42 ± 9.5 years (95% CI: 41.4--42.7 years). The prevalence of obesity following BMI criteria (≥30 kg/m^2^) was 17.5% (95% CI: 15.1%--20.2%), reaching 19.9% (95% CI: 16.7%--23.4%) in men, and 13.5% (95% CI: 10%--17.6%; *p* \< 0.001) in women. However, according to the body fat percentage of the CUN-BAE, global obesity prevalence was 53% (95% CI: 49.7%--56.3%), at 57.5% (95% CI: 53.3%--61.6%) in men and 45.2% (95% CI: 39.8%--50.7%) in women (*p* \< 0.001). [Table 1](#ijerph-16-04529-t001){ref-type="table"} summarizes the main characteristics of sample n~1~.

3.2. Bivariate Analysis and Unadjusted Linear Regression {#sec3dot2-ijerph-16-04529}
--------------------------------------------------------

With respect to the BMI categories, statistically significant differences were found between the BMI categories and age, weight, and BF% according to the CUN-BAE (*p* \< 0.001). The means of age, weight, and BF% increased from one category to the next, and the means were lower in the underweight category and higher in the obesity category (*p* \< 0.001).

A direct correlation between the BF% using CUN-BAE and weight (*r* = 0.273), age (*r* = 0.373), BMI (*r* = 0.640), and its Napierian logarithm (LnBMI) (*r* = 0.625) was observed. We found an inverse correlation with height (*r* = −0.478). All the correlations found were statistically significant (*p* \< 0.001).

The correlation between predictive variables and body fat (CUN-BAE) was higher when each sex was analyzed independently, and higher in women than in men, except for BMI ([Table 2](#ijerph-16-04529-t002){ref-type="table"}).

Finally, after performing unadjusted regression models, BMI was the best variable adjusting to CUN-BAE, with a coefficient of determination (*R*^2^) of 0.408, followed by LnBMI (*R*^2^ = 0.390). The determination coefficients were higher for women, except for BMI ([Table 3](#ijerph-16-04529-t003){ref-type="table"}).

3.3. Multiple Linear Regression Models (Adjusted) and Clinical Agreement of the Proposed Models {#sec3dot3-ijerph-16-04529}
-----------------------------------------------------------------------------------------------

[Table 4](#ijerph-16-04529-t004){ref-type="table"} presents the multiple linear regression models (adjusted, BF%~n~) obtained for the prediction of body fat percentage together with the correlation and goodness-of-fit of the model with respect to the reference model (CUN-BAE).

The BF%~1~ model explained 98.5% of the variability of the fat percentage estimated by the CUN-BAE formula and has a coefficient of clinical agreement of 0.992 (95% CI: 0.991--0.993). Although the BF%~2~ model explained 95.8% of the variability, the clinical agreement coefficient was 0.625 (95% CI: 0.584--0.663). Similarly, the BF%~3~ model accounted for 97.3% of the variability but its ICC was 0.631 (95% CI: 0.590--0.670).

When age is incorporated into two models (BF%~2~ and BF%~3~), the equations obtained agreed more with the CUN-BAE, although the variations in the adjusted coefficient of determination are not significant. The BF%~4~ model explained 98.6% of the variability and had a higher correlation and similar agreement to that demonstrated by the first model (0.993; 95% CI: 0.992--0.994). Finally, BF%~5~ best fit CUN-BAE. This model explained a greater variability (99.6%), had better correlation (0.998) and a higher clinical agreement (0.998; 95% CI: 0.997--0.998).

We found the correlation and clinical agreement of sex were reduced in BF%~1~ and BF%~2~ for both men and women. A similar phenomenon occurred with BF%~3~, except that it maintained the correlation at 0.986 for women. The BF%~5~ model remained robust for both measurements, its correlation was not altered and its ICC only diminished by one thousandth ([Table 5](#ijerph-16-04529-t005){ref-type="table"}), which confirms its predictive superiority compared to the other models.

[Table 6](#ijerph-16-04529-t006){ref-type="table"} and [Figure 1](#ijerph-16-04529-f001){ref-type="fig"} show that according to the Bland--Altman graphs, the model with the greatest clinical concordance is BF%~5~, demonstrating a difference in means and a lower dispersion than the other models.

Depending on sex ([Table 6](#ijerph-16-04529-t006){ref-type="table"}), model BF%~5~ agreed the best with CUN-BAE. As such, the BF%~5~ was considered the best equation for estimating body fat and we called it the Equation Cordoba for Estimation of Body Fat (ECORE-BF).

3.4. Validation of the ECORE-FW Method with n~2~ Sample {#sec3dot4-ijerph-16-04529}
-------------------------------------------------------

Of the 2000 workers composing sample n~2~, 1022 (51.1%) were women, with a global mean age of 43.6 ± 10.9 years (95% CI: 43.1--44.0). The mean BMI was 26.7 ± 5.5 g/m^2^ (95% CI: 26.6--27.0). Given the characteristics of n~2~, statistically significant differences were found between sex, age, and BMI with respect to sample n~1~. With respect to the body fat percentage, the mean was 33.7 ± 10.6% (95% CI: 33.2--34.2) and 31.9 ± 8.8% (95% CI: 31.5--32.3) for CUN-BAE and ECORE-BF, respectively.

The correlation obtained between both methods for estimating the body fat percentage (CUN-BAE and ECORE-BF) was 0.994. With regard to sex, the correlation increased to 0.998 for men and women. For the clinical agreement, we observed that the global ICC value was 0.960 (95% CI: 0.957--0.964). For men and women, the ICC was 0.997 (95% CI: 0.997--0.998) and 0.910 (95% CI: 0.897--0.917), respectively.

We found a difference in the Bland--Altman agreement means of 1.819 (±2.079), the limits being −2.256 and 5.895. In terms of sex, the difference in means for men was 0.032 (±0.487), with the limits of −0.922 and 0.985, and 3.531 (±1.498) with the limits for 0.595 and 6.470 for women ([Figure 2](#ijerph-16-04529-f002){ref-type="fig"}).

4. Discussion {#sec4-ijerph-16-04529}
=============

The objective of this study was to develop and validate an equation that would simplify the CUN-BAE equation considering the principle of parsimony for multivariate modeling \[[@B21-ijerph-16-04529]\].

First, the prevalence of overweight (41.7%) and obesity (17.5%) found in sample n~1~ according to BMI criteria was higher than that presented by the WHO in its latest report \[[@B7-ijerph-16-04529]\]. Sex-wise, the men showed a significantly higher proportion of obesity than the women, which has already been observed in a working population \[[@B26-ijerph-16-04529]\]. However, the BMI taken as a single reference, as has been reported previously \[[@B33-ijerph-16-04529]\], underestimates obesity prevalence as it does not differentiate fat mass from muscle mass \[[@B14-ijerph-16-04529]\]. The results show how the obesity prevalence rises to 53% when studied in terms of the percentage of body fat. Regardless, most field studies use BMI as a classification method \[[@B34-ijerph-16-04529]\] and it is also employed as an estimator of the body fat percentage \[[@B35-ijerph-16-04529]\] due to the good correlation (*r* = 0.640) found in different populations \[[@B36-ijerph-16-04529]\].

However, although the BMI and other indexes are used to estimate body fat \[[@B17-ijerph-16-04529]\], in their calculation, they do not include important variables like age (*r* = 0.373) and sex \[[@B15-ijerph-16-04529]\]. Sex has an increased correlation with all variables, especially BMI *(r* = 0.640 at 0.970 for men and 0.969 for women).

New estimation equations adjusted for sex and age improve the versions that do not include those variables in their adjustment \[[@B21-ijerph-16-04529]\]. In this respect, we observed how BMI (BF%~2~ and BF%~4~) improved capacity to explain the variability when age and sex were incorporated (*R*^2^ = 0.408 up to *R*^2^ = 0.986) and had high levels of clinical agreement. Age is the variable least modifying the goodness-of-fit the model evaluated through the adjusted coefficient of determination \[[@B26-ijerph-16-04529]\].

Liu et al. \[[@B37-ijerph-16-04529]\] published three equations to estimate the body fat in the Chinese population and successfully explained 81.1% of the variability. As with CUN-BAE, it is a complex formula with over six terms and including one more variable, the waist perimeter. Similarly, Kanellakis et al. \[[@B38-ijerph-16-04529]\] proposed two methods for the estimation of body fat but, despite possessing good intraclass correlation values (0.955 and 0.976), the formulas presented are complicated and require several anthropometric measurements.

The validation of several estimation formulas in different populations has produced highly variable results in the adjustment with respect to the reference method, obtaining *R*^2^ values between 0.66 and 0.77 \[[@B39-ijerph-16-04529]\]. The validation in menopausal women showed similar results, with a high dispersion in the estimation of body fat, and the formulas, including the BMI, explained the variability best over and above skin folds \[[@B40-ijerph-16-04529]\]. However, the use of the transformation of the BMI by calculating its Napierian logarithm (LnBMI) significantly improves the fit of the models presented (BF%~3~ and ECORE-BF). Individually, the LnBMI poorly fitted the estimated value of the BF% (*R*^2^ = 0.390) compared with BMI. However, when introducing sex and age into the equation, the explanation of the variability rose to 99.6% and the clinical agreement increased both globally and when differentiated by sex. These values were maintained when applying the formula to another working population with similar characteristics, showing better fits that other studies that used the bioelectrical impedance analysis (BIA) as the gold standard \[[@B26-ijerph-16-04529]\]; the latter has not shown a good correlation when using the DXA as a reference test \[[@B41-ijerph-16-04529]\].

In all the formulas proposed, the BMI was the variable most influencing the determination of body fat, followed by sex. This changed with the incorporation of LnBMI in which the sex was the variable with more influence (0.788). Thus, this variable increases in importance in body fat determination due to women having 10% more body fat on average \[[@B32-ijerph-16-04529]\]. The results established based on standardized β coefficients cannot be compared with other works because they have not been published.

The use of estimation equations may cause various problems as the correlation of the formulas developed vary depending on the reference method used \[[@B42-ijerph-16-04529]\] and on the selection of the reference population \[[@B34-ijerph-16-04529]\]. For those reasons, as posited by other authors \[[@B9-ijerph-16-04529]\], the use of one model or another has to be conditioned by the population studied and by its situation or condition. In addition to the other factors mentioned, the ethnic group may also be a determining factor \[[@B13-ijerph-16-04529]\], which complicates the comparison of the results. Furthermore, most of the estimation formulas used in the literature were validated in highly varied populations with distinct characteristics, which complicates their use in current populations \[[@B38-ijerph-16-04529]\]. The proposed equation was developed and validated in a population with similar characteristics to that studied by the CUN-BAE, so it is suitable for use in a similar population.

Another issue arising in this study is that a tendency exists to overestimate body fat in slim people and underestimate it in obese people, regardless of the method used \[[@B18-ijerph-16-04529]\]. This has been amply corroborated \[[@B43-ijerph-16-04529]\] and causes the correlations found to be lower than the most up-to-date values \[[@B38-ijerph-16-04529]\]. This situation is aggravated when the overweight or obesity present extreme values, which may affect the CUN-BAE formula as it was calculated by employing the ADP \[[@B44-ijerph-16-04529]\] as a reference.

The above evidence demonstrates the need to use equations that best adapt themselves to a specific population with given characteristics (sportspeople, pathologies, slim people, etc.) \[[@B9-ijerph-16-04529],[@B45-ijerph-16-04529],[@B46-ijerph-16-04529],[@B47-ijerph-16-04529],[@B48-ijerph-16-04529],[@B49-ijerph-16-04529]\].

Despite these difficulties, using estimation formulas continues to be a feasible strategy as it guarantees a reduction in the costs and time required to take measurements \[[@B45-ijerph-16-04529]\]. In addition, the formulas have shown a good correlation for the detection of the risk of prevalent pathologies and cardiovascular danger factors \[[@B16-ijerph-16-04529],[@B21-ijerph-16-04529],[@B50-ijerph-16-04529]\]. Formulas based on skin folds guarantee a good correlation with respect to DXA \[[@B20-ijerph-16-04529]\], but anthropometric measurements, especially in extreme cases like obesity, cause underestimation problems due to their measurement difficulties \[[@B51-ijerph-16-04529]\]. However, no formula or method is free from limitations \[[@B13-ijerph-16-04529],[@B17-ijerph-16-04529],[@B52-ijerph-16-04529],[@B53-ijerph-16-04529],[@B54-ijerph-16-04529]\].

Given the above, we think that employing ECORE-BF is an efficient method for the estimation of body fat could guarantee accuracy, speed, and simplicity. Since only weight and height are required for its calculation in clinical settings, only basic anthropometry skills from healthcare professionals are necessary. However, as a surrogate method was used as a reference for its development and the population with which the formula was validated (individuals with work capacity and aged between 18 and 65 years), these limitations should be highlighted. Despite these limitations, the CUN-BAE showed a high correlation concerning ADP (*r* = 0.89) and a strong association with chronic health problems \[[@B21-ijerph-16-04529],[@B22-ijerph-16-04529],[@B55-ijerph-16-04529]\]. For this reason, the simpler ECORE-BP could be useful when more precise tools are not available.

Limitations
-----------

The main limitation of this study is that a gold standard, such as ADP or DXA, was not used. The use of the CUN-BAE as a reference method does not allow evaluating the real capacity of the proposed method to estimate body fat, due to the limitations of the original equation. Therefore, future work should compare the results obtained by ECORE-BP with more precise methods such as those mentioned. Another limitation of the study is that we found variability in the composition of samples n~1~ and n~2~ in terms of sex, age, and BMI. Nevertheless, the model was shown to be accurate in both samples, even when we found significant differences between them. ECORE-BP not being more accurate on a particular population over another could be one strength of this formula.

5. Conclusions {#sec5-ijerph-16-04529}
==============

ECORE-BF is a simplification of the CUN-BAE formula that produced precise results with a reduction of the components involved in its calculation. Since ECORE-BF followed the principle of parsimony from multiple regressions, the new formula could be considered as a methodological improvement on CUN-BAE. This simplification is an adaptation of the formula that increased its usability in clinical settings, only requiring basic anthropometry skills from healthcare professionals. ECORE-BF could be applied in settings where more precise tools or specifically trained personnel are not available, or when exposure to radiation must be avoided.
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ijerph-16-04529-t001_Table 1

###### 

Description of sample n~1~.

  ----------------------------------------------------------------------------------
  Variable        Total\          Men\          Women\        *p*          
                  *n* = 906       *n* = 572     *n* = 334                  
  --------------- --------------- ------------- ------------- ------------ ---------
  Age (years)     42 (9.5)        42.3 (9.9)    41.3 (8.7)    0.071        

  Weight (kg)     75.4 (15)       81.6 (12.9)   64.6 (12.2)   \<0.001      

  Height (m)      168.9 (8.8)     173.4 (6.4)   161.2 (6.5)   \<0.001      

  BMI (kg/m^2^)   26.3 (4.4)      27.1 (3.9)    24.9 (4.7)    \<0.001      

                  Underweight     11 (1.2%)     5 (0.9%)      6 (1.8%)     0.221

  Normal weight   358 (39.5%)     168 (29.4%)   190 (56.9%)   \<0.001      

  Overweight      378 (41.7%)     285 (49.8%)   93 (27.8%)    \<0.001      

  Obesity         159 (17.5%)     114 (19.9%)   45 (13.5%)    \<0.05       

  CUN-BAE         29.6 (7.3)      26.4 (5.7)    34.9 (6.5)    \<0.001      

                  Normal weight   137 (15.1%)   58 (10.1%)    79 (23.7%)   \<0.001

  Overweight      289 (31.9%)     185 (32.3%)   104 (31.1%)   0.707        

  Obesity         480 (53%)       329 (57.5%)   151 (45.2%)   \<0.001      
  ----------------------------------------------------------------------------------

Note: BMI, body mass index; CUN-BAE, Clínica Universidad de Navarra-Body Adiposity Estimator.

ijerph-16-04529-t002_Table 2

###### 

Bivariate correlation by sex using CUN-BAE.

  Sex     Age          Weight       Height        BMI          LnBMI
  ------- ------------ ------------ ------------- ------------ ------------
  Men     0.471 \*\*   0.822 \*\*   −0.115 \*     0.970 \*\*   0.977 \*\*
  Women   0.541 \*\*   0.868 \*\*   −0.225 \*\*   0.969 \*\*   0.986 \*\*

Note: \* *p* \< 0.01; \*\* *p* \< 0.001; BMI, body mass index; Ln: Napierian logarithm.

ijerph-16-04529-t003_Table 3

###### 

Raw simple regression.

  Global                                                                             
  -------- ------- ---------- -------------------- -------- ------- ---------------- ---------
  Age      0.138   17.589     15.594--19.584       0.285    0.024   0.239--0.332     \<0.001
  Sex      0.318   26.433     25.948--26.937       8.552    0.415   7.708--9.336     \<0.001
  Weight   0.074   19.587     17.246--21.928       0.113    0.016   0.102--0.163     \<0.001
  Height   0.227   96.788     88.708--104.868      −0.398   0.024   −0.446--−0.350   \<0.001
  BMI      0.408   1.370      −0.874--3.614        1.072    0.043   0.988--1.156     \<0.001
  LnBMI    0.390   −63.445    −71.044--−55.847     28.562   1.187   26.232--30.892   \<0.001
  Men                                                                                
  Age      0.221   14.974     13.160--16.789       0.270    0.021   0.228--0.312     \<0.001
  Weight   0.675   −3.419     −5.141--−1.696       0.366    0.011   0.345--0.387     \<0.001
  Height   0.011   44.118     31.542--56.694       −0.102   0.037   −0.174--−0.029   \<0.001
  BMI      0.940   −12.453    −13.268--−11.637     −1.434   0.015   1.287--1.359     \<0.001
  LnBMI    0.955   −105.321   −107.677--−102.964   40.046   0.364   39.330--40.761   \<0.001
  Women                                                                              
  Age      0.291   18.248     15.387--21.115       0.405    0.035   0.337--0.472     \<0.001
  Weight   0.752   5.070      3.188--6.951         0.462    0.015   0.433--0.491     \<0.001
  Height   0.048   71.521     54.453--88.590       −0.227   0.054   −0.333--−0.121   \<0.001
  BMI      0.939   1.977      1.056--2.897         1.323    0.018   1.287--1.359     \<0.001
  LnBMI    0.971   −82.439    −84.616--−80.263     36.685   0.345   36.006--37.364   \<0.001

Note: BMI, body mass index; Ln: Napierian logarithm; *R*^2^*,* coefficient of determination (goodness of fit); SE, standard error; CI, confidence interval.
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###### 

Multiple linear regression models.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Model                                                                                                                                     Standardized Beta Coefficient   R^2^    SE      *r*     *p*     
  ----------------------------------------------------------------------------------------------------------------------------------------- ------------------------------- ------- ------- ------- ------- ---------
  $\mathbf{BF}\%_{1}$\                                                                                                                      Age                             0.185   0.985   0.888   0.992   \<0.001
  $52.316~ + ~0.142~\left( {age} \right) + ~11.521~\left( {sex} \right) + ~0.456~\left( {weight} \right)~–~0.399~\left( {height} \right)$                                                                   

  Sex                                                                                                                                       0.763                                                           

  Weight                                                                                                                                    0.941                                                           

  Height                                                                                                                                    −0.478                                                          

  $\mathbf{BF}\%_{2}$\                                                                                                                      Sex                             0.764   0.958   1.496   0.979   \<0.001
  $- 11.034~ + ~11.535~\left( {sex} \right)~ + ~1.382~\left( {BMI} \right)$                                                                                                                                 

  BMI                                                                                                                                       0.824                                                           

  $\mathbf{BF}\%_{3}$\                                                                                                                      Sex                             0.793   0.973   1.202   0.986   \<0.001
  $- 100.045~ + ~11.982~\left( {sex} \right)~ + ~38.442~\left( {LnBMI} \right)$                                                                                                                             

  LnBMI                                                                                                                                     0.841                                                           

  $\mathbf{BF}\%_{4}$\                                                                                                                      Age                             0.176   0.986   0.871   0.993   \<0.001
  $- 14.181~ + ~0.134~\left( {age} \right)~ + ~11.483~\left( {sex} \right)~ + ~1.288~\left( {BMI} \right)$                                                                                                  

  Sex                                                                                                                                       0.760                                                           

  BMI                                                                                                                                       0.768                                                           

  $\mathbf{BF}\%_{5}$\                                                                                                                      Age                             0.161   0.996   0.461   0.998   \<0.001
  $- 97.102~ + ~0.123~\left( {age} \right)~ + ~11.900~\left( {sex} \right)~ + ~35.959~\left( {LnBMI} \right)$                                                                                               

  Sex                                                                                                                                       0.788                                                           

  LnBMI                                                                                                                                     0.787                                                           
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Note: BF%~n~, body fat estimation model; Sex, men = 0, women = 1; BMI, body mass index; Ln: Napierian logarithm; *R*^2^, coefficient of determination (goodness of fit); SE, standard error; *r*, Pearson's linear correlation.
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###### 

Bivariate correlation and ICC by sex.

  ---------------------------------------------------------------------------------------------------------------
  Gold Standard   Test             BF%~1~           BF%~2~           BF%~3~           BF%~4~           BF%~5~
  --------------- ---------------- ---------------- ---------------- ---------------- ---------------- ----------
  Men                                                                                                  

  CUN-BAE         *r*              0.991 \*         0.970 \*         0.977 \*         0.993 \*         0.998 \*

  ICC             0.991\           0.481\           0.492\           0.992\           0.997\           
                  (0.989--0.992)   (0.415--0.541)   (0.427--0.551)   (0.991--0.994)   (0.996--0.997    

  Women                                                                                                

  CUN-BAE         *r*              0.987 \*         0.969 \*         0.986 \*         0.985 \*         0.998 \*

  ICC             0.985\           0.606\           0.600\           0.985\           0.997\           
                  (0.982--0.988)   (0.533--0.669)   (0.527--0.664)   (0.981--0.988)   (0.996--0.998)   
  ---------------------------------------------------------------------------------------------------------------

Note: *\* p* \< 0.001; 95% CI shown in parentheses; BF%~n~, body fat estimation model; CUN-BAE, Clínica Universidad de Navarra-Body Adiposity Estimator; *r*, Pearson's linear correlation; ICC, intraclass correlation coefficient.
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###### 

Model agreement with CUN-BAE.

  Model    Mean Difference (±SD)   *p*     95% CI
  -------- ----------------------- ------- -------------------
  Global                                   
  BF%~1~   −0.002 (±0.899)         0.959   −1.763 to 1.760
  BF%~2~   0 (±6.249)              1.000   −12.247 to 12.247
  BF%~3~   0 (±6.227)              1.000   −12.205 to 12.205
  BF%~4~   −0.002 (±0.886)         0.948   −1.739 to 1.735
  BF%~5~   −0.000 (±0.466)         0.989   −0.913 to 0.913
  Men                                      
  BF%~1~   −0.002 (±0.776)         0.961   −1.523 to 1.519
  BF%~2~   −1.351 (±6.226)         1.000   −13.553 to 10.851
  BF%~3~   1.298 (±6.138)          1.000   −13.329 to 10.733
  BF%~4~   −0.001 (±0.688)         0.977   −1.349 to 1.348
  BF%~5~   0 (±0.440)              0.991   −0.863 to 0.863
  Women                                    
  BF%~1~   −0.001 (±1.079)         0.981   −2.115 to 2.113
  BF%~2~   2.314 (±5.581)          1.000   −8.625 to 12.252
  BF%~3~   2.224 (±5.738)          1.000   −9.023 to 13.470
  BF%~4~   −0.004 (±1.150)         0.953   −2.258 to 2.251
  BF%~5~   −0.001 (±0.507)         0.973   −0.994 to 0.993

Note: BF%~n~, body fat estimation model; CI, confidence interval.
